Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1
Melanotan II - Indications, Uses, and Side Effects Dec 132021 Background Melanotan II was first developed at the University of Arizona
You Could Benefit from GHK-Cu Injections GHK-Cu injections may be a supportive option if youre noticing changes in your skin or hair with age, recovering from a procedure or injury, or feeling like your body isnt bouncing back the way it used to
Retatrutide, a single peptide targeting GIP, GLP-1, and glucagon receptors, has shown remarkable results in early-phase studies